v3.25.2
Note 11 - Aemetis Biogas LLC - Series A Preferred Financing (Details Textual) - USD ($)
$ / shares in Units, $ in Thousands
12 Months Ended 44 Months Ended
May 07, 2025
Dec. 20, 2018
Dec. 31, 2022
Aug. 08, 2022
Jun. 30, 2025
Dec. 31, 2024
Financial Instruments Subject to Mandatory Redemption, Settlement Terms, Share Value, Amount, Noncurrent         $ 128,880 $ 126,593
Debt Instrument, Variable Interest Rate, Type [Extensible Enumeration] Prime Rate [Member]          
Credit Agreement [Member] | Protair-X and Third Eye Capital [Member]            
Debt Instrument, Basis Spread on Variable Rate 10.00%          
Debt Instrument, Interest Rate, Stated Percentage 16.00%          
Common Units [Member]            
Common Stock, Capital Shares Reserved for Future Issuance (in shares)   5,000,000        
Preferred Units Series A [Member]            
Common Units Authorized (in shares)   11,000,000        
Preferred Units, Authorized (in shares)   6,000,000        
Preferred Units Series A [Member] | Second Tranche [Member            
Preferred Units, Issued (in shares)     6,000,000      
Preferred Units Issued Value     $ 30,000      
Stock Redeemed or Called During Period, Shares (in shares)       20,000    
Preferred Units Redeemed, Value       $ 300    
Series A Preferred Stocks [Member]            
Common Units Issued (in shares)   6,000,000        
Common Units Issuance Value (in dollars per share)   $ 5        
PUPA Ninth Amendment [Member]            
Preferred Units Issued Value $ 116,800          
Preferred Units, Aggregate Redemption Price, Incremental Fee $ 2,000          
Financial Instruments Subject to Mandatory Redemption, Settlement Terms, Share Value, Amount, Noncurrent         $ 128,900 $ 126,600